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Abstract
Objective: Clinically, anorexia nervosa (AN) presents with altered body composition.
We quantified these alterations and evaluated their relationships with metabolites
and hormones in patients with AN longitudinally.
Method: In accordance with PRISMA guidelines, we conducted 94 meta-analyses on
62 samples published during 1996–2019, comparing up to 2,319 pretreatment, post-
treatment, and weight-recovered female patients with AN with up to 1,879 controls. Pri-
mary outcomes were fat mass, fat-free mass, body fat percentage, and their regional
distribution. Secondary outcomes were bone mineral density, metabolites, and hormones.
Meta-regressions examined relationships among those measures and moderators.
Results: Pretreatment female patients with AN evidenced 50% lower fat mass (mean
difference [MD]: −8.80 kg, 95% CI: −9.81, −7.79, Q = 1.01 × 10−63) and 4.98 kg
(95% CI: −5.85, −4.12, Q = 1.99 × 10−28) lower fat-free mass, with fat mass preferen-
tially stored in the trunk region during early weight restoration (4.2%, 95% CI: −2.1,
Abbreviations: AN, anorexia nervosa; BIA, bioelectrical impedance analysis; DSM, Diagnostic and Statistical Manual of Mental Disorders; DXA, dual-energy X-ray absorptiometry; MD, mean
difference; MRI, magnetic resonance imaging; NOS, Newcastle–Ottawa Scale.
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−6.2, Q = 2.30 × 10−4). While the majority of traits returned to levels seen in healthy
controls after weight restoration, fat-free mass (MD: −1.27 kg, 95% CI: −1.79, −0.75,
Q = 5.49 × 10−6) and bone mineral density (MD: −0.10 kg, 95% CI: −0.18, −0.03,
Q = 0.01) remained significantly altered.
Discussion: Body composition is markedly altered in AN, warranting research into
these phenotypes as clinical risk or relapse predictors. Notably, the long-term altered
levels of fat-free mass and bone mineral density suggest that these parameters
should be investigated as potential AN trait markers.
Resumen
Objetivo: Clínicamente, la anorexia nervosa (AN) se presenta con alteraciones en la
composición corporal. Cuantificamos estas alteraciones y evaluamos lon-
gitudinalmente su relación con metabolitos y hormonas en pacientes con AN.
Método: De acuerdo con las pautas PRISMA, realizamos 94 meta-análisis en 62 muestras
publicadas entre 1996–2019, comparando hasta 2,319 pacientes mujeres en pre-tratamiento,
post-tratamiento, y recuperadas en base al peso con hasta 1,879 controles. Las principales
medidas fueron masa grasa, masa libre de grasa, porcentaje de grasa corporal y su distribución
regional. Las medidas secundarias fueron densidad mineral ósea, metabolitos y hormonas. Las
meta-regresiones examinaron las relaciones entre esas medidas y moderadores.
Resultados: Las pacientes femeninas con AN pre-tratamiento mostraron un 50%
menos de masa grasa (MD: −8.80 kg, CI 95%: −9.81, −7.79, Q = 1.01 × 10–63) y
4.98 kg (CI 95%: −5.85, −4.12, Q = 1.99 × 10–28) menos de masa libre de grasa, con
masa grasa preferentemente almacenada en la región del tronco durante la rec-
uperación temprana del peso (4.2%, CI 95%: −2.1, −6.2, Q = 2.30 × 10–4). Aunque la
mayoría de los rasgos regresaron a los niveles vistos en los controles sanos después
de la restauración del peso, la masa libre de grasa (MD: −1.27 kg, CI 95%: −1.79,
−0.75, Q = 5.49 × 10–6) y la densidad mineral ósea (MD: −0.10 kg, CI 95%: −0.18,
−0.03, Q = 0.01) permanecieron significativamente alteradas.
Discusión: La composición corporal es marcadamente alterada en la AN, lo que gar-
antiza la investigación en estos fenotipos como predictores de riesgo clínico o de
recaída. Notablemente, la alteración a largo plazo de los niveles de masa libre de grasa
y densidad mineral ósea sugieren que estos parámetros debe ser investigados como
potenciales rasgos indicadores de AN.
K E YWORD S
BIA, binge-eating/purging, bioelectrical impedance analysis, body fat percentage, bone, dual-
energy X-ray absorptiometry, DXA, estradiol, fat-free mass, insulin, lean mass, long-term follow-
up, restricting, thyroid, weight restoration
1 | INTRODUCTION
Anorexia nervosa (AN) has one of the highest mortality rates of all psychi-
atric disorders (Chesney, Goodwin, & Fazel, 2014). Clinical observations
show altered body composition (El Ghoch, Calugi, Lamburghini, & Dalle
Grave, 2014; Solmi et al., 2016) accompanied by elevated cholesterol
(Hussain et al., 2019) and greater insulin sensitivity (Ilyas et al., 2018).
However, conclusions are limited by small sample sizes and consequent
mixed findings.
Molecular genetic studies have revealed that individuals with AN
carry genetic variants that increase their liability to AN and concur-
rently predispose them to lower body fat percentage, lower fasting
1206 HÜBEL ET AL.
insulin, and higher high-density lipoprotein cholesterol concentrations,
suggesting that metabolic factors may play an etiological role (Duncan
et al., 2017; Watson et al., 2019). Additionally, longitudinal investiga-
tions of a British birth cohort showed that girls who develop AN later
in life are already underweight at the age of 4 years when compared
to healthy children (Yilmaz, Gottfredson, Zerwas, Bulik, & Micali,
2019), adding evidence for a developmental component.
A systematic review showed that adolescents and adults differ-
ently lose fat tissue when affected by AN, with adolescents losing
more central fat tissue and adults more peripheral fat tissue. During
weight recovery, individuals with AN show emergent central adiposity
which typically attenuates over time (El Ghoch, Calugi, et al., 2014).
These clinical and genetic findings encourage the meta-analytic
reassessment of the role of body composition traits, such as fat mass
and fat-free mass, their regional distribution, and their changes associ-
ated with weight restoration and long-term weight recovery in AN.
Meta-analyses have four major advantages compared to systematic
reviews. Increasing statistical power through pooling results from inde-
pendent samples leads to more precise estimates of the underlying
effect. Meta-analyses estimate the heterogeneity (i.e., inconsistency)
among effect sizes from the individual studies included, which are cru-
cial for the interpretation of the pooled estimates. Meta-regressions are
used to investigate potential moderators of the pooled effect sizes and
the relationships between the outcomes of interest, while extensions of
meta-analytical models can estimate potential publication bias
(Nakagawa, Noble, Senior, & Lagisz, 2017).
The goals of these meta-analyses were to (a) replicate findings from
the systematic review on fat mass; (b) extend the observations by quan-
tifying them; (c) include fat-free mass; (d) include bone mineral content
and density; (e) investigate their associations with each other; and (f) if
possible, relate findings to secondary outcomes, such as metabolic and
hormonal parameters. This analytical approach is aimed at understand-
ing the potential associations between these factors that are known to
be physiologically interrelated. A thorough and rigorous examination of
body composition and related laboratory parameters in individuals with
AN could elucidate some of the physiological changes associated with
this serious disorder, which could lead to more effective medical man-
agement, monitoring, and treatment approaches.
2 | METHOD
2.1 | Search strategy, selection criteria, and data
extraction
Our meta-analysis was conducted according to PRISMA guidelines
(Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009) and pre-
registered (PROSPERO 2018 CRD42018105338) with no changes to
the protocol. We conducted a literature search from June 15, 2018,
until July 15, 2019, using the electronic databases PubMed and Web
of Science with a time limitation starting with articles published after
January 1, 1994—marking the introduction of the Diagnostic and Sta-
tistical Manual of Mental Disorders, 4th Edition (DSM-IV; American
Psychiatric Association, 2013). We used key search terms including
“anorexia nervosa” AND (“body composition” OR “body fat” OR “fat
mass” OR “body fat percentage” OR DXA OR BIA OR “fat free mass”
OR “lean mass”). The search was repeated by coauthors to avoid
selection bias. Furthermore, we screened the references of published
articles and reviews. Our search results, including the selection pro-
cess, are presented in Figure 1 according to PRISMA guidelines. Our
selection criteria are presented in Table 1. In case of multiple publica-
tions deriving from the same study population, we selected the arti-
cles reporting either the largest or the most recent data set. In case of
conflict between these two criteria, large sample size was prioritized.
We extracted the information presented in Table 1 from every identi-
fied study using a standardized data extraction sheet.
The data extraction sheet was based on two previous meta-
analyses (Hussain et al., 2019; Ilyas et al., 2018) and included variables
that were hypothesized to be associated with body composition, hor-
monal, or metabolic measures, including fasting status and period,
medications, stage of the menstrual cycle, or treatments for longitudi-
nal studies. If enough studies reported these variables, we performed
meta-regressions to investigate their associations with our primary
and secondary outcomes.
2.2 | Quality of study assessment (Newcastle–
Ottawa scale)
We used the Newcastle–Ottawa Scale (NOS) to assess the quality of
nonrandomized studies (Wells et al., 2009). Each study is judged on
three broad perspectives: (a) the selection of the study groups; (b) the
comparability of the groups; and (c) the ascertainment of the outcome
of interest for case–control studies. The NOS evaluates these three
quality parameters divided across eight specific items. Each item on
the scale is scored from one point, except for comparability, which
can be adapted to the specific topic of interest to score up to two
points. It has been designed to be used in meta-analyses and system-
atic reviews. For the observational studies, low quality was defined as
NOS score ≤8.0 and high quality as score >8.0 (maximum score 9).
2.3 | Meta-analysis
Inverse variance-weighted meta-analyses for females and males separately
were conducted using the statistical package “meta” and “metafor” in the
open-source software R v3.5.1 (r-project.org). We used additional formulas
to calculate missing values (Hozo, Djulbegovic, & Hozo, 2005; Luo, Wan,
Liu, & Tong, 2018;Wan, Wang, Liu, & Tong, 2014). As effect sizes, we esti-
mated mean differences (MDs) between individuals with AN and controls.
We chose a random-effects model, which assumes that the heterogeneity
in the differences between clinical and control groups is due to both
within-study and between-study variation, as we anticipated differences in
procedures and study populations between studies. We quantified the het-
erogeneity through a restricted maximum-likelihood (REML) approach. For
the analysis of subtypes, posttreatment, and weight-recovered patients
with AN, the control groups from the acutely-ill/pretreatment analysis
were reused because (a) control groups were not measured repeatedly and
(b) none of the studies had separate control groups for each subtype
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analysis. Although some studies included covariates in their statistical anal-
ysis (Bratland-Sanda et al., 2010; Bredella et al., 2008; Dellava, Policastro, &
Hoffman, 2009; DiVasta et al., 2007; Fernández-Soto, González-Jiménez,
Chamorro-Fernández, & Leyva-Martínez, 2013; Haas et al., 2005; Karlsson,
Weigall, Duan, & Seeman, 2000; Kosmiski, Schmiege, Mascolo, Gaudiani, &
Mehler, 2014; Maïmoun et al., 2018; Nakahara et al., 2007; Schneider
et al., 1998), we only used raw values without including study-specific
covariates to increase comparability across individual studies. Weight
recovery was defined in accordance with DSM-IV and DSM-5 criteria with
BMI >18.5 kg/m2 or >90% ideal body weight. To correct our primary anal-
ysis for multiple testing, false discovery rate–adjusted Q values were calcu-
lated (Benjamini & Hochberg, 1995).
2.4 | Detection and adjustment for publication bias
The results of meta-analyses can be influenced by publication bias
(i.e., small study effects). This describes the phenomenon when certain
studies have been selected for publication, while others—mostly due
to negative findings—have not been published (Nieminen, Rucker,
Miettunen, Carpenter, & Schumacher, 2007). Through graphical diag-
nosis of asymmetry in funnel plots (Egger, Smith, Schneider, & Minder,
1997) and performing Thompson and Sharp tests (i.e., weighted linear
regressions) that take variation between studies into account
(Thompson & Sharp, 1999), we investigated potential small study
effects or publication bias. If the test resulted in a p value below .05,
we adjusted the pooled effect estimates using a Copas selection
model calculated with the R package “metasens.” The model has two
components: the first component estimates the pooled effect, while
the second estimates a publication probability for each study. A large
correlation between these two components suggests that studies with
more extreme effects were more likely to be published (Copas, 1999;
Copas & Shi, 2000, 2001). The models were iteratively optimized
using two tuning parameters γ0 and γ1. We present four diagnostic
graphics including (a) a funnel plot, (b) a contour plot, (c) a treatment
effect plot, and (d) a p value plot.
2.5 | Investigation of potential moderators through
meta-regression and stratification
To examine the large between-study heterogeneity per meta-
analysis (Table 1), we performed meta-regressions using mixed
effects models included in the R package “meta” that take the het-
erogeneity within and between individual studies into account. The
models were optimized via a REML approach. Through meta-regres-
sion, we investigated whether relevant participant or study charac-
teristics may be associated with the pooled estimates, such as mean
age, the time period of follow-up for longitudinal studies, age at
diagnosis, age at menarche, age at amenorrhea, duration of illness,
percentage of amenorrhea in patients with AN, percentage of medi-
cated patients with AN, percentage of individuals taking
F IGURE 1 PRISMA (Preferred
Reporting Items for Systematic Reviews
and Meta-Analyses) flow diagram of
study selection
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contraceptives, body composition measurement method, blood sam-
ple type, body composition parameters, and their differences
between cases and controls.
A second approach to test for potential moderators is stratifica-
tion of the sample into meaningful subgroups and estimation of statis-
tical differences between the pooled estimates per subgroup. We
used this approach and stratified by AN subtype.
3 | RESULTS
3.1 | Results of the search and selection of studies
A total of 1,498 papers published between 1996 and 2019 were iden-
tified by our search terms, and 1,434 (96%) of them were excluded.
No paper published during 1994–1996 fulfilled the inclusion criteria,
and the most common reasons for exclusion apart from not investigat-
ing AN or being a review were (a) no control group (n = 182, 12%);
(b) no main outcome reported (i.e., body composition; n = 75, 5%); and
(c) sample overlap (n = 73, 5%). Detailed exclusion process is pres-
ented in Figure 1. Sixty-four published articles (4%) were included in
our analysis, and we became aware of no additional unpublished sam-
ples after contacting study authors for additional or missing data
(Table S1). The majority of studies focused on female cases and controls
that were sampled consecutively in only 22 of 62 samples (35%,
Table S2) and aged between 13.8 and 31.3 years (Figure S1). As such,
four studies (6%) investigating male AN cases were investigated in a
separate quantitative synthesis and are discussed briefly (El Ghoch, Cal-
ugi, Milanese, Bazzani, & Dalle Grave, 2017; Marra et al., 2019; Misra
et al., 2013; Schorr et al., 2019). Three studies (5%) originated from Aus-
tralasia, 38 (61%) from Europe, 15 (24%) from North America, and
6 (10%) from Asia. Only 13 studies (21%) used the same method of
ascertainment for cases and controls (Table S2). Twenty-nine studies
(47%) investigated inpatients, 8 (13%) outpatients, 2 (3%) a mixture of
both, and 23 studies (37%) did not specify the recruitment or patient-
setting. Twenty-seven studies (44%) comprised collection of blood sam-
ples after a fasting period, whereas only six studies (10%) specified the
fasting period (Bredella et al., 2012; DiVasta et al., 2011; Dostálová,
Sedlácková, Papezová, Nedvídková, & Haluzík, 2009; Estour et al.,
2017; Kaválková et al., 2012; Prioletta et al., 2011). One study (3%) did
not specify whether analyses were performed using plasma or serum
blood (Weinbrenner et al., 2004). Seventeen studies (27%) sampled reg-
ular menstruating participants during the follicular phase of their cycle
(de Alvaro et al., 2007; Dostálová et al., 2009; Estour et al., 2017; Gal-
usca et al., 2015; Germain et al., 2010, 2007, 2016; Grinspoon et al.,
2001; Kaválková et al., 2012; Kirchengast & Huber, 2004; Mayer et al.,
2005, 2009; Nakai, Hamagaki, Takagi, Taniguchi, & Kurimoto, 1999;
Prioletta et al., 2011; Scalfi et. al, 2002; Weinbrenner et al., 2004),
whereas 14 studies (23%) did not provide details about the cycle phase
(Bachmann et al., 2014; Bredella et al., 2012; Delporte, Brichard,
Hermans, Beguin, & Lambert, 2003; DiVasta et al., 2011; Fazeli et al.,
2010; Fernández-Soto et al., 2013; Germain et al., 2010; Gniuli, Liv-
erani, Capristo, Greco, & Mingrone, 2001; Grinspoon et al., 1996; Guo,
Jiang, Liao, Liu, & He, 2013; Haas et al., 2005; Karczewska-Kupczewska
et al., 2010; Maïmoun et al., 2018; Mörkl et al., 2017; Nakahara et al.,
2007; Rigaud, Boulier, Tallonneau, Brindisi, & Rozen, 2010; Tagami
et al., 2004; Tanaka et al., 2003). However, studies were retained to
achieve the largest possible sample size, and––depending on data
availability––meta-regressions were fitted to investigate study charac-
teristics as possible moderators. Originally, 41 studies (66%) were cross-
sectional and 21 were longitudinal (34%, Table S1). However, four of
the longitudinal studies (19%) were analyzed cross-sectional in our
TABLE 1 Selection criteria and extracted data from the original
publications
Selection criteria
a. Studies investigating humans only
b. Any age group
c. No sample overlap
d. Observational cross-sectional or longitudinal studies or
randomized-controlled trials
e. Clinical diagnoses of AN according to the DSM IV–5, or their
revisions (American Psychiatric Association, 2013), or ICD-10
(World Health Organization, 1992)
f. Investigation of body composition by dual-energy X-ray
absorptiometry (Bredella et al., 2010, 2013), bioelectrical impedance
analysis (BIA) (Bonaccorsi et al., 2012; Mattar et al., 2011), dual photon
absorptiometry, or magnetic resonance imaging (Mayer et al., 2005).
g. Published or collected after January 1, 1994 (the year that DSM-IV
was introduced)
h. The study includes a control group or comparison group
i. Publications in any language which could be translated by the
research team: English, German, Swedish, Danish, Spanish
Extracted data
a. Author, publication year
b. Country
c. Sample sizes including gender and age
d. Setting: Inpatient or outpatient
e. Original longitudinal or cross-sectional design
f. Follow-up period if longitudinal
g. Diagnostic criteria: DSM-IV, DSM-IV-TR, DSM-5, or ICD-10
h. Participant screening and exclusion criteria
i. Number of cases: AN pretreatment, posttreatment (ANpost),
recovered from AN (ANrec)
j. Subtype of AN: Restricting (R), binge eating/purging
k. Number of controls
l. Primary outcome variables of body composition: Fat mass, fat-free
mass, body fat percentage, and their regional distribution
m. Secondary outcome variables, which were reported by at least
three studies additional to primary outcomes: Bone mineral
density, glucose, insulin, ghrelin, adiponectin, leptin, insulin-like
growth factor, estradiol, testosterone, cortisol, thyroid-stimulating
hormone, free triiodothyronine, free thyroxine
n. Covariates used in original analysis
o. Fasting and fasting duration
p. Blood sample: Serum, plasma, or unspecified
q. Medication and contraceptives
r. Psychological and additional treatments
s. Outcome was a secondary or primary outcome in the original study
t. Duration of illness
u. Age at diagnosis/onset
v. Age at menarche
w. Percentage of AN cases with amenorrhea and duration of amenorrhea
Abbreviations: AN, anorexia nervosa; ICD-10, International Classification of
Diseases version 10; DSM, Diagnostic and Statistical Manual of Mental
Disorders.
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meta-analysis due to missing data. No control group was repeatedly
measured in any of the longitudinal studies.
3.2 | Characteristics of the included studies
We performed four sets of meta-analyses (a) comparing 2,319 pre-
treatment/acutely ill AN patients with 1,879 healthy controls;
(b) comparing 722 post-treatment AN patients with 809 controls;
(c) estimating the change in AN patients (n = 722) from pretreatment
to posttreatment; and (d) comparing 398 weight-recovered individuals
with AN with 660 healthy controls including samples with a long-term
follow-up. The pretreatment AN group comprised 229 individuals suf-
fering from the binge-eating/purging (8% of cases) and 701 from the
restricting subtype (26% of cases). The shortest follow-up period was
5.14 weeks, and the longest was 2 years (Table S1). Twenty studies
(32%) used bioelectrical impedance analysis (BIA) to assess body com-
position, 39 (63%) used dual-energy X-ray absorptiometry (DXA), and
only 3 (5%) utilized magnetic resonance imaging (MRI)––considered to
be the benchmark. Thirty of the 62 studies (48%) investigated body
composition as a primary outcome, whereas it was a secondary out-
come in the remaining studies. The percentage of AN patients with
amenorrhea ranged from 0 to 100%, with 11 studies (18%) not pro-
viding information on menstrual status (Agüera et al., 2015;
Bachmann et al., 2014; Bredella et al., 2012; de Mateo Silleras et al.,
2013; El Ghoch et al., 2012; Gniuli et al., 2001; Iacopino et al., 2003;
Kirchengast & Huber, 2004; Schneider et al., 1998; Tagami et al.,
2004; Tanaka et al., 2003). Thirty-five of 62 studies (56%) did not pro-
vide information on the medication status of AN patients, and
32 (52%) did not indicate whether oral contraceptives were used. In
AN cases, the duration of illness was on average 52.2 months
(SD = 29.4), the duration of amenorrhea 23.0 months (SD = 18.3), and
the age at diagnosis 17.5 years (SD = 3.0). Cases and controls were
well matched for age (Figure S1) and, notably, we did not observe a
difference in age at menarche (Figure S2) or height (Figure S5)
between AN cases and controls.
3.3 | Data and analyses results of meta-analyses and
meta-regressions
Our results from the 94 meta-analyses show that a wide range of
alterations in several key body composition and biochemical measures
exist in AN cases compared with healthy controls (Figure 2 and
Figure S3). For 95% confidence intervals and Q values, heterogeneity
estimates (τ2 and I2), and adjusted estimates due to estimated publica-
tion bias, see Table 2. Detailed forest plots showing each of the
94 meta-analyses are presented as Figures S4–S89 for females and
Figures S90–S95 for males. No differences between restricting and
binge-eating/purging subtype of AN were detected in our meta-
analysis prior to treatment except for total body water (Table S3).
Between-study heterogeneity (I2) was observed in 62 meta-analyses
(70%) and ranged from 52 to 99%, confirming our choice of a
random-effects model. To investigate moderators implicated in het-
erogeneity, we performed 411 meta-regressions (Tables S4–S7). Six
meta-analyses showed funnel plot asymmetry, indicating small study
effects. Therefore, we fitted Copas models to adjust for those effects
and estimate the probable number of unpublished studies (Table 1
and Figures S96–S101).
3.4 | Primary outcomes: Body composition
3.4.1 | Anthropometrics
On average, pretreatment female AN cases had a 15.64 kg (95% CI:
−16.98, −14.30, Q = 5.59 × 10−114) lower body weight and were
0.01 m (95% CI: −0.02, 0.00, Q = 0.02) shorter than healthy controls
(Table S4). After treatment, female AN patients still weighed 4.92 kg
(95% CI: −8.03, −1.81, Q = 1.92 × 10−3) less than healthy controls.
Before treatment, male AN cases weighed 15.48 kg (95% CI: −22.42,
−8.54, Q = 1.80 × 10−5) less than healthy controls and showed no dif-
ferences in height compared with controls.
Correspondingly, the pretreatment BMI difference between
female AN cases and controls was −5.81 kg/m2 (95% CI: −6.25,
−5.38, Q = 2.83 × 10−152), which reduced to −2.10 kg/m2 (95% CI:
−2.53, −1.67, padjCopas < .0001) after treatment as most patients
gained on average 9.93 kg (95% CI: 8.17, 11.68, Q = 2.11 × 10−27)
during treatment. Posttreatment BMI in females was primarily
accounted for by gains in fat mass (βmetareg = 0.81, p = 7.03 × 10
−7)
but not through fat-free mass (Table S5). After weight recovery, no
statistically significant MD in BMI between female AN cases and con-
trols was detected. The pretreatment BMI difference between male
AN cases and controls was −5.48 kg/m2 (95% CI: −7.87, −3.09,
Q = 1.80 × 10−5).
3.4.2 | Fat mass
The pretreatment body composition of individuals with AN was signif-
icantly altered. Compared with healthy controls, female AN cases had
8.80 kg (95% CI: −9.81, −7.79, Q = 1.01 × 10−63) lower fat mass,
corresponding to a 13.9% (95% CI: −15.1, −12.6, Q = 5.49 × 10−101;
Figure 3) lower total body mass. Male AN cases had 5.87 kg (95% CI:
−8.98, −2.75, Q = 2.70 × 10−4) lower fat mass, corresponding to 7.5%
(95% CI: −10.8, −4.2, Q = 1.8 × 10−5) lower total body mass. This sug-
gests that body fat was on average 50% lower than in healthy con-
trols. Body fat percentage (βmetareg = −134.53, p = 0.01) and absolute
fat mass (βmetareg = −35.50, p = 2.03 × 10−5) were associated with
whole-body bone mineral density of female AN patients. Absolute fat
mass was also associated with mean age at diagnosis (βmetareg = −1.21,
p = 2.42 × 10−4) in females (Table S4).
After treatment, female AN patients had a 2.37 kg (95% CI: −3.75,
−0.98, Q = 0.002) lower fat mass, which corresponded to 2.5% (95%
CI: −4.3, −0.7, padjCopas = 0.006) less total body mass compared with
healthy controls. Female AN patients gained 6.39 kg (95% CI: 5.13,
7.65, Q = 3.07 × 10−22) fat mass following treatment, which cor-
responded to 10.4% (95% CI: 7.96, 12.87, Q = 6.25 × 10−16) of total
body mass. Posttreatment fat mass (βmetareg = −0.23, p = .01;
Table S5) and gain in fat mass during treatment (βmetareg = −0.20,
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p = .02; Table S6) were negatively associated with the presence of
amenorrhea. Following weight recovery, these values fully returned to
levels seen in female healthy controls.
Specifically, compared with healthy controls, female AN patients
had 3.51 kg (95% CI: −4.58, −2.43, Q = 8.07 × 10−10) less trunk fat
mass prior to treatment. In relative terms, however, female AN
patients had lower extremity body fat with 5.4% (95% CI: −8.4, −2.4,
Q = 8.23 × 10−4) less total body mass. The presence of amenorrhea
was significantly associated with lower extremity fat mass
(βmetareg = 0.31, p = .04; Table S4).
After treatment, female AN patients showed a higher trunk body
fat percentage than controls at 12.0% (95% CI: 9.5, 14.4,
padjCopas < 1.00 × 10
−4) of total body mass. However, this finding
was strongly influenced by publication bias with an estimated
52 unpublished studies. These results on body composition were not
influenced by height as female and male cases and controls showed
no meaningful difference (i.e., 1 cm pretreatment) or by age as meta-
regressions were nonsignificant (Tables S4–S7).
3.4.3 | Fat-free mass
Overall, the fat-free mass in female AN patients was 4.98 kg (95% CI:
−5.85, −4.12, Q = 1.99 × 10–28; Figure 4) lower before treatment
than in controls, corresponding to 12.3% (95% CI: 8.1, 16.5,
F IGURE 2 Summary plot of all
88 meta-analyses comparing female AN
cases with healthy controls. The plot
shows the Q values (i.e., the false
discovery rate-corrected p values) of
each inverse variance-weighted random-
effects meta-analyses comparing AN
cases pretreatment (purple, n = up to
2,294), posttreatment (light green, n = up
to 722), and after weight recovery (dark
green, n = up to 398) with healthy
controls (n = up to 2,251). Restricted
maximum-likelihood estimator was used
to estimate heterogeneity. Q values are
transformed on the -log10 scale,
multiplied by the sign of the mean
difference (MD) and presented on the x-
axis. Points lying in the yellow area
indicate no statistically significant mean
difference between AN cases and
healthy controls after correction for
multiple testing (i.e., Q > 0.05). Points to
the left of the yellow area indicate a
lower mean value in AN cases than in
controls, whereas points on the right of
the yellow area indicate a higher mean
value in AN cases than in controls. A
dark green point outside the yellow area
indicates a significant difference
between AN cases and controls after
weight recovery (a) The outcomes with
the largest differences between cases
and controls. (b) The less extreme mean
differences. The x-axis was capped at
-log10(Q value) × sign(MD) = −0.25. The
full figure is presented as Figure S3
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3
4
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1
8
.5
0
−
1
1
.3
3
−
1
5
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8
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−
2
2
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2
,−
8
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4
1
.2
2
×
1
0
−
5
1
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0
×
1
0
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0
5
1
7
.9
4
6
9
.8
%
0
.0
%
,9
3
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%
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7
H
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gh
t
3
4
2
4
4
−
0
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3
0
.0
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−
0
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2
m
−
0
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4
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1
.1
3
0
.1
3
0
.0
0
0
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%
0
.0
%
,8
2
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%
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5
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o
dy
m
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s
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x
4
6
8
9
2
−
9
.0
0
−
3
.7
0
−
5
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8
kg
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2
−
7
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7
,−
3
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9
6
.9
2
×
1
0
−
0
6
1
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0
×
1
0
−
0
5
5
.5
8
9
4
.2
%
8
8
.2
%
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7
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%
3
.6
5
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1
0
−
1
1
0
.8
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8
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–
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4
.9
kg
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2
F
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m
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4
2
4
4
−
8
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0
−
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3
−
5
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7
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−
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8
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2
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2
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1
0
−
0
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2
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1
0
−
0
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6
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7
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7
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.5
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5
.5
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7
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−
0
4
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t
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ta
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4
6
8
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2
−
9
.7
0
−
2
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0
−
7
.4
9
%
−
1
0
.7
9
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4
.1
9
8
.7
6
×
1
0
−
0
6
1
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0
×
1
0
−
0
5
9
.8
4
8
5
.7
%
6
4
.8
%
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4
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%
1
.0
7
×
1
0
−
0
4
0
.7
0
1
2
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–
1
4
%
F
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e
m
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3
4
2
4
4
−
1
0
.2
0
−
5
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5
−
9
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7
kg
−
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2
.4
7
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7
3
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0
×
1
0
−
0
9
2
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0
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1
0
−
0
8
0
.0
0
0
.0
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6
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3
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e
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.9
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4
3
6
4
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0
1
6
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0
9
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8
.1
7
,1
1
.6
8
1
.4
4
×
1
0
−
2
8
2
.1
1
×
1
0
−
2
7
7
.5
4
8
0
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%
6
5
.0
%
,8
8
.0
%
1
.3
5
×
1
0
−
7
0
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2
H
ei
gh
t
2
1
4
6
1
4
6
0
.0
0
0
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1
0
.0
0
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−
0
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1
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.0
2
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7
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5
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3
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x
1
8
7
2
2
8
0
7
1
.1
6
6
.4
0
3
.3
9
kg
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2
2
.7
1
,4
.0
8
4
.1
9
×
1
0
−
2
2
4
.1
0
×
1
0
−
2
1
1
.9
9
9
5
.0
%
9
4
.0
%
,9
7
.0
%
8
.5
4
×
1
0
−
6
8
0
.3
7
1
8
.5
–
2
4
.9
kg
/m
2
F
at
m
as
s
1
5
5
8
9
6
3
6
−
0
.8
6
8
.9
0
6
.3
9
kg
5
.1
3
,7
.6
5
2
.7
9
×
1
0
−
2
3
3
.0
7
×
1
0
−
2
2
5
.4
2
9
5
.0
%
9
3
.0
%
,9
6
.0
%
7
.6
6
×
1
0
−
4
9
0
.6
8
B
o
dy
fa
t
pe
rc
en
ta
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1
4
5
3
0
5
3
0
3
.8
5
1
5
.7
0
1
0
.4
1
%
7
.9
6
,1
2
.8
7
9
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3
×
1
0
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1
7
6
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×
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6
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9
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1
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3
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0
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3
F
at
-f
re
e
m
as
s
1
2
6
3
4
7
1
9
0
.0
0
6
.9
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2
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1
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4
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×
1
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6
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3
.8
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3
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Q = 3.21 × 10−8) higher proportion of total body mass. In males, fat-
free mass in AN patients was −9.37 kg (95% CI: −12.47, −6.27,
Q = 2.00 × 10−8) lower before treatment than in controls. During treat-
ment, female AN patients gained 2.98 kg (95% CI: 1.74, 4.22,
Q = 6.89 × 10−6) fat-free mass, resulting in 1.82 kg (95% CI: −2.57,
−1.08, Q = 5.41 × 10−6) lower fat-free mass compared to controls. Yet,
weight-recovered female individuals with AN still showed 1.27 kg (95%
CI: −1.79, −0.75, Q = 5.49 × 10−6) lower fat-free mass than controls.
More specifically, pretreatment fat-free mass of the extremities in
females was 1.5% (95% CI: −2.0, −1.0, Q = 8.84 × 10−9) less of total
body mass. After treatment, no marked regional differences in fat-free
mass were observed in female AN patients. However, weight-
recovered female individuals with AN had 0.9% (95% CI: −1.3, −0.5,
Q = 6.30 × 10−5) lower trunk fat-free mass of total body mass than
controls.
Before treatment, we observed a 393.95 kcal/day (95% CI:
−531.04, −256.86, Q = 6.53 × 10−8) lower resting energy expenditure
and 4.77 L (95% CI: −6.13, −3.41, Q = 3.06 × 10−11) less total body
water in female AN patients, which persisted with 3.71 L (95% CI:
−7.07, −0.36, Q = 0.05) after treatment. Both were measured by BIA.
However, resting energy expenditure was not corrected for fat-free
mass or body mass in the original studies, limiting its interpretability.
Before treatment, total body water in females was associated with fat
mass (βmetareg = 0.60, p = .01) and the difference in fat-free mass
between AN cases and controls (βmetareg = 0.48, p = .003).
Before treatment, only the amount of total body water was signifi-
cantly different between female individuals (psubgroup = 1.47 × 10
−4)
suffering from the restricting (−5.31 L, 95% CI: −8.15, −2.47,
pR = 2.47 × 10
−4, k = 4) or the binge-eating/purging subtype (−11.1 L,
95% CI: −12.04, −10.16, pBP = 5.06 × 10−119, k = 1; Table S3). How-
ever, this finding was limited by only one study investigating the
binge-eating/purging subtype).
3.5 | Secondary outcome: Bone mineral measures
3.5.1 | Bone mineral content and density
Compared with healthy controls, whole-body bone mineral content in
female individuals with AN was 0.16 kg (95% CI: −0.19, −0.12,
Q = 2.73 × 10−20) lower before treatment and 0.09 kg (95% CI: −0.13,
−0.05, Q = 1.63 × 10−5) lower after treatment. Weight-restored female
individuals with AN showed 0.10 kg (95% CI: −0.18, −0.03, Q = 0.01)
lower whole-body bone mineral content compared to controls as they
gained on average 0.05 kg (95% CI: 0.02, 0.09, Q = 0.01) during treat-
ment. The interpretability of these estimates is limited due to the insuffi-
cient follow-up time after weight recovery, exceeding 6 months in only
F IGURE 3 Cross-sectional meta-
analysis of studies reporting body fat
percentage in acutely-ill/pretreatment
female AN patients compared with
healthy controls. Forty-four samples had
the appropriate data for the meta-
analysis with 2,179 AN cases and 1,803
controls. A random-effects meta-analysis
revealed a pooled estimate of the mean
difference (MD: −13.8%; 95% CI: −15.1,
−12.6; Q = 5.49 × 10−101) with the mean
differences ranging from −24.6% to
−5.5%. Heterogeneity between studies
was statistically significant (τ2 = 15.84;
p = 1.40 × 10−98; I2 = 92.8%). C, subtype-
combined sample
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two studies (Dellava et al., 2009; Karlsson et al., 2000). The pretreatment
whole-body bone mineral content in females was associated with fat-
free mass (βmetareg = 0.02, p = .02) and fat mass (βmetareg = 0.05, p = .02),
as well as the difference in fat mass between AN patients and controls
(βmetareg = 0.04, p = .002; Table S4). Accordingly, pretreatment whole-
body bone mineral density was 0.03 g/cm2 (95% CI: −0.06, −0.01,
padjCopas = .02) lower in females with AN, but our analysis showed a den-
sity comparable with healthy controls posttreatment. However, only two
studies with 74 AN cases could be included in this analysis.
Before treatment, female AN patients exhibited lower bone min-
eral density in several regions, including hip, lumbar spine, and femoral
neck, with a few being likely to persist after weight recovery. These
findings were associated with duration of illness, the age of AN cases,
and differences in fat mass between cases and controls (Supporting
Information: Secondary Outcomes: Detailed Bone Mineral Measures
and Table S4). Cases and controls in our meta-analyses were age- and
height-matched (Figures S1 and S6); therefore, these variables are
unlikely to be associated with these results.
3.5.2 | Secondary outcomes: Metabolites and
hormones
Exploratory results showed that fasting insulin and glucose concentra-
tions were lower in female AN patients compared with controls but
not associated with fat or fat-free mass, while lower leptin was associ-
ated with fat mass pretreatment. After treatment, these measures
returned to concentrations seen in healthy controls. Before treatment,
thyroid hormones, cortisol, and IGF-1 were lower in female AN
patients, and all three measures were associated with fat mass,
whereas higher cortisol in AN patients was associated with fat-free
mass. For detailed results, see Supporting Information: Secondary
Outcomes: Metabolites and Hormones.
3.5.3 | Methodological moderators
We observed strong between-study heterogeneity (Table 1). To investi-
gate how differences in study design, samples, and measurement
methods may influence the primary and secondary outcomes, we per-
formed an additional set of meta-regressions (Tables S4–S7). The method
of body composition measurement was associated with pretreatment
body fat percentage (βDXA = 3.05, p = .01), fat-free mass (βIsotope Dilu-
tion = −6.18, p = .008), and fat-free mass percentage (βDXA = −8.28,
p = .01), and posttreatment body fat percentage (βDXA = 6.39, p = .005) in
females. Furthermore, femoral neck bone mineral density
(βOutpatient = −0.12, p = 7.65 × 10−4) significantly differed between female
inpatients and outpatients.
4 | DISCUSSION
Our primary meta-analyses showed marked alterations in body com-
position traits in patients with AN before and after treatment. Before
treatment, all three major body compartments—fat, fat-free, and bone
F IGURE 4 Cross-sectional meta-
analysis of studies reporting fat-free mass
content in acutely-ill/pretreatment
female AN patients compared with
healthy controls. Thirty-seven samples
had the appropriate data for the meta-
analysis with 2,319 AN cases and 1,879
controls. A random-effects meta-analysis
revealed a pooled estimate of the mean
difference (MD: −4.98 kg; 95% CI: −5.8,
−4.1; Q = 1.99 × 10−28) with the mean
differences ranging from −12.16 to
0.20 kg. Heterogeneity between studies
was statistically significant (τ2 = 5.92;
p = 1.22 × 10−58; I2 = 90.5%). C, subtype-
combined sample
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mass—showed significant reductions that were only partially restored
after treatment. Our meta-analysis estimated ~50% lower body fat in
AN patients which was mirrored by leptin concentrations (Perry &
Shulman, 2018), both of which recovered with treatment. In females,
significant differences were observed in body fat distribution after
treatment as body fat is primarily stored in the trunk. This distribution
pattern may be due to increased insulin sensitivity observed in AN
patients (Ilyas et al., 2018) potentially similar to observations in
healthy individuals after short-term overfeeding (McLaughlin et al.,
2016). We did not detect meaningful or statistically significant differ-
ences in body fat distribution in weight-restored patients, indicating
potential redistribution occurring over longer term follow-up.
A new finding from our meta-analysis is that lower fat mass in
females with AN was correlated with significantly low bone mineral
content and density across the whole body. We speculate that the
hormonal cross-talk between fat and bone tissue may be influencing
this association (El Ghoch et al., 2016; Hawkes & Mostoufi-Moab,
2018), potentially mediated through greater bone marrow adipose tis-
sue observed in AN (Fazeli & Klibanski, 2018; Suchacki & Cawthorn,
2018). Whole-body bone mineral content remained low in weight-
recovered individuals with AN. However, as only two studies followed
patients for longer than 6 months (Dellava et al., 2009; Karlsson et al.,
2000), the duration of follow-up was insufficient to draw firm conclu-
sions because bone mineral mass is slow to normalize. Future studies
should be designed to capture long-term changes. In men with AN, fat
mass and fat-free mass were lower before treatment than in controls.
However, long-term follow-up studies are missing. It has been
reported that short-term weight restoration may normalize body com-
position patterns but could also lead to central adiposity (El Ghoch,
Calugi, et al., 2017), but sample sizes of reports of males are very
small. Additionally, in our analysis alterations in bone mineral mass did
not affect the height of individuals with AN.
Another new finding in our meta-analysis is that we observed a 5 kg
lower fat-free mass in female AN patients, which remained lower even
after treatment and in weight-recovered AN patients, indicating that
current treatment regimens may insufficiently target fat-free mass.
Future studies should also assess muscle mass to identify the compo-
nents of fat-free mass that are most associated with this reduction.
Our secondary outcomes—associations between detailed body
composition and laboratory parameters in AN—were difficult to assess
as only a few published studies reported both outcomes consistently.
Most biochemical alterations were within the range of normal refer-
ence values. However, serious alterations can occur in certain individ-
uals with AN that warrant vigilance by clinicians.
Pretreatment fasting insulin and glucose were reduced in AN
patients independent of fat mass, but both concentrations normalized
following treatment, suggesting that increased insulin sensitivity (Ilyas
et al., 2018) may be a temporary state in AN. The relationship
between AN and insulin sensitivity should be investigated by
euglycemic hyperinsulinemic clamp that showed mixed findings in
very small samples (Castillo, Scheen, Jandrain, & Lefèbvre, 1994; Cas-
tillo, Scheen, Lefebvre, & Luyckx, 1985; Dostálová et al., 2009;
Karczewska-Kupczewska et al., 2010; Pannacciulli et al., 2003;
Prioletta et al., 2011; Zuniga-Guajardo, Garfinkel, & Zinman, 1986).
This approach is supported by epidemiological associations of AN
with type 1 diabetes (Hedman et al., 2018) and its genetic overlap
with fasting insulin (Duncan et al., 2017), type 2 diabetes (Watson
et al., 2019), and insulin sensitivity (Hübel et al., 2018).
AN was associated with body fat percentage-associated low T3-
and T4-syndrome pretreatment, whereas thyroid-stimulating hormone
concentrations were normal. Associations between fat mass and thyroid
hormones have been described before (Kwon et al., 2018); however,
sufficiently powered long-term follow-up studies in AN are absent.
Steroid hormone concentrations were altered showing high corti-
sol, low estradiol, and normal testosterone. Estradiol was negatively
associated with fat-free mass, whereas cortisol was positively associ-
ated with fat mass. These findings suggest that fat-free mass may be a
potential moderator for the return of menses in AN patients and
should be further investigated as most research in recovery of menses
primarily focused on BMI- or weight-related cutoffs (Misra et al.,
2006; Swenne, 2004). Potential reverse causation should also be
taken into account where altered estradiol concentrations may pre-
cede changes in fat-free mass.
Overall, the meta-analyzed study sample was highly selected and
biased as it comprised mostly European females aged between 14 and
31 years, emphasizing the urgent need for studies including diverse
ancestries, such as Asia, South and Central America, and Africa.
Females and males differ in body composition and metabolic charac-
teristics (Karastergiou & Fried, 2017; Link & Reue, 2017), unde-
rscoring the need for more studies on males with AN. Our study
selection was limited by the lack of control groups and underreported
extensive sample overlap. Moreover, control groups were only
measured at baseline in all longitudinal studies, failing to account for
age- and growth-related variation, potentially inflating estimates. Fur-
thermore, no clear-cut and consistent definition of recovery from AN
was used across studies, contributing to heterogeneity (Murray,
Loeb, & Le Grange, 2018). This underscores the necessity of develop-
ing standard definitions of remission and recovery in the eating disor-
ders field (Bardone-Cone, Hunt, & Watson, 2018).
Methodologically, we observed effects of either BIA or DXA on
the measurement of body composition in AN, questioning the compa-
rability of the two methods. Larger, longitudinal validation studies
comparing both methods with whole-body MRI in eating disorders
should be conducted. Additional factors influencing body composition
and biochemical measures, such as menstrual cycle, diurnal changes,
fasting, and preanalytical procedures are summarized in Table 3 and
should be carefully assessed in future studies (Hernandes et al., 2017).
Most importantly, blood comprises approximately 3,500 highly
correlated and interacting proteins (hupo.org; Schwenk et al., 2017)
and 4,600 metabolites (serummetabolome.ca; Psychogios et al.,
2011); therefore, the measurement of single proteins, hormones, or
metabolites is ill-advised. Metabolomics, proteomics, and lipidomics
can capture large amounts of information at adequate statistical
power when used in large samples (Hernandes et al., 2017). Addition-
ally, large epidemiological databases that have measured biomarkers
in childhood, such as the Avon Longitudinal Study of Parents and
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Children (ALSPAC; Golding, Pembrey, Jones, & ALSPAC Study Team,
2001) and Generation R (Kooijman et al., 2016), should be harnessed
to determine whether those who go on to develop AN show evidence
for premorbid differences in body composition and biochemical
parameters as has been observed for BMI by Yilmaz et al. (2019).
5 | CONCLUSIONS
Detailed measurement of body composition with simple methods,
such as BIA or DXA, which offers additional information on bone tis-
sue, may help refine our understanding of the nature of AN and its
diagnosis. Our meta-analyses showed that all body compartments
were markedly altered in AN. Individuals with AN presented with 50%
lower fat mass and prolonged recovery periods for fat-free mass and
bone mineral content. The core implication of body composition dif-
ferences are alterations in metabolism, growth, and development.
Although results must be interpreted with caution given small sam-
ples, we found evidence indicating alterations in fasting insulin, thy-
roid, sex, and stress hormones in AN, which appeared to partially
normalize with weight gain and recovery. Large birth cohorts that col-
lected information on eating disorders along with metabolomic infor-
mation offer a rich and exciting opportunity for prospective
investigations that add to our understanding of body composition and
metabolic mechanisms in risk and maintenance of eating disorders.
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TABLE 3 Minimum requirement of variables that should be assessed, reported, and included in statistical analyses of case–control studies
examining anorexia nervosa or other eating disorders to facilitate reproducibility, meta-analysis, and meta-regression
Sampling Sample characteristics
Cases and controls
• Underlying population: community, hospital
• Consecutive sample or selection
• If consecutive, attrition and reasons
• Diagnosis and ascertainment
• Diagnostic schema
• Independent validation
Controls
• Repeated measurement at follow-up
• Exclusion of current and history of diagnosis (i.e., screening)
• Matching (e.g., age, sex)
• Exclusion criteria
Cases and controls
• Age
• Biological sex and gender
• Height
• Weight
• Body mass index
• Ancestry
• Socioeconomic status & education
Cases
• Age of onset
• Duration of illness
Body composition Menstrual status
• Fat mass
• Fat-free mass
• Bone mineral content and density
• Ideally: Muscle mass
• Measurement method: e.g., MRI, DXA, or BIA
• Physical activity (ideally accelerometer data)
Cases
• Dysmenorrhea or amenorrhea
• Duration of amenorrhea
• Age of menarche
• If menstruating, stage or day of cycle
Controls
• Stage or day of the menstrual cycle (e.g., follicular phase)
Blood sampling Substances
• Blood sample type whole blood, serum, plasma
• Fasting state
• Fasting period
• The time point of blood sampling
• Pre-analytics
• Storage
• Storage duration
Dose and duration of
• Contraceptives
• Supplements & vitamins
• Medication
 Prescription
 Over the counter
• Laxatives
• Illicit drugs
• Alcohol consumption
• Smoking behavior
aAdapted from Hernandes, Barbas, & Dudzik, 2017. Abbreviations: BIA, bioelectrical impedance analysis; DXA, dual-energy X-ray absorptiometry; MRI,
magnetic resonance imaging.
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